Skip to main content

Table 1 (abstract A35). Analysis of OraQuick ADVANCE cross-reactivity with plasma samples from vaccine recipients

From: Abstracts from the 4th Annual Student Medical Summit

HIV-1 Diagnostic Test Participants Testing Reactive
n (%) 		p value vs OraQuick ADVANCE
OraQuick ADVANCE 1 of 57 (1.8%) ----
BioRad GS 53 of 57 (93%) < 0.0001
Abbott Architect 54 of 57 (95%) < 0.0001
Alere Determine 52 of 57 (91%) < 0.0001
Abbott Prism1 1 of 1 (100%) ----
  1. 1 Abbott Prism was only used if samples tested negative on all three of the fourth-generation antigen/antibody tests (n=15)
Back to article page

BMC Proceedings

ISSN: 1753-6561

Contact us